MARICO LIMITED vs NATH BIO-GENES (I) LTD
A side-by-side comparison of MARICO LIMITED (MARICO) and NATH BIO-GENES (I) LTD (NATHBIOGEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, MARICO LIMITED leads MARICO vs NATHBIOGEN on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation04
- Profitability40
- Growth11
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
NATHBIOGEN takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
MARICO takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
EvenThree-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
MARICO takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%", "Company has been maintaining a healthy dividend payout of 65.1%"]
- − ["Stock is trading at 25.6 times its book value", "The company has delivered a poor sales growth of 11.1% over past five years."]
- + ["Stock is trading at 0.44 times its book value", "Debtor days have improved from 110 to 70.0 days."]
- − ["Tax rate seems low", "Company has a low return on equity of 5.93% over last 3 years.", "Earnings include an other income of Rs.15.2 Cr.", "Dividend payout has been low at 9.52% of profits over last 3 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.